NFKB1 and obesity disorder: It has been further demonstrated that NF-κB antagonizes the transcriptional activity of Nrf2 [32], suggesting that in a pro-inflammatory state, typical of diabetes and obesity, NF-κB activation impairs Glo1 expression by inhibiting Nrf2 action.